SOD2 and cancer: The obtained results indicate that individuals with brain tumors displayed specific changes in antioxidant status; thus, in patients with benign brain tumors, decreased TotSOD and MnSOD activities and increased SH group concentrations were observed, while patients with malignant tumors were characterized by increased GST activity and decreased AChE activity.